Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2025 | An overview of biomarker-informed trials in renal cell carcinoma

Simpa Salami • 20 Feb 2025
GU Cancers 2025
Genitourinary Cancer Kidney Cancer

Simpa Salami, MD, MPH, University of Michigan, Ann Arbor, MI, gives an overview of recent advances in biomarkers in renal cell carcinoma (RCC) clinical trials. Current trials such as the BIONIKK trial (NCT02960906) are evaluating how biomarkers can be applied in clinical practice. This interview took place at the ASCO GU Cancers Symposium 2025 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Simpa Salami

The potential applications of ctDNA in renal cell carcinoma
1:17
The potential applications of ctDNA in renal cell carcinoma
Simpa Salami • 20 Feb 2025
The future of biomarkers in renal cell carcinoma
1:30
The future of biomarkers in renal cell carcinoma
Simpa Salami • 20 Feb 2025
Emerging technologies in the development of RCC biomarkers
1:04
Emerging technologies in the development of RCC biomarkers
Simpa Salami • 20 Feb 2025

Related Videos

Enzalutamide outcomes & duration predictors in mHSPC: ARCHES post hoc analyses
3:04
Enzalutamide outcomes & duration predictors in mHSPC: ARCHES post hoc analyses
Andrew Armstrong • 3 Jun 2026
Chemo-IO in neuroendocrine or aggressive variant metastatic prostate cancer
2:24
Chemo-IO in neuroendocrine or aggressive variant metastatic prostate cancer
Andrew Armstrong • 3 Jun 2026
Treatment sequencing after EV plus pembrolizumab in metastatic bladder cancer
2:10
Treatment sequencing after EV plus pembrolizumab in metastatic bladder cancer
Tian Zhang • 1 Jun 2026
Highlights in ADCs for bladder cancer at ASCO 2026
1:29
Highlights in ADCs for bladder cancer at ASCO 2026
Tian Zhang • 1 Jun 2026
The content of VJOncology is intended for healthcare professionals